Kovack Advisors, Inc. Novo Cure LTD Transaction History

Kovack Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$116.17 - $194.55 $268,120 - $449,021	-2,308 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$130.4 - $225.58 $46,031 - $79,629	353 Added 18.06%	2,308 $512,000
Q1 2021 May 04, 2021	SELL	$124.11 - $190.17 $7,446 - $11,410	-60 Reduced 2.98%	1,955 $258,000
Q4 2020 Jan 14, 2021	BUY	$112.16 - $174.14 $226,002 - $350,892	2,015 New	2,015 $349,000
Q1 2020 Apr 30, 2020	SELL	$57.05 - $95.75 $157,914 - $265,036	-2,768 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$61.86 - $97.8 $171,228 - $270,710	2,768 New	2,768 $207,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.